A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Phase ? Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetic Characteristics of MWN101 Injection in the Treatment of Type 2 Diabetes Mellitus.

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 193039f37328e4da5bf41ee55e6716e3d69272b2
First added on: Apr 24, 2026